No Data
No Data
ScPharmaceuticals Announces Participation in Three Upcoming Investor Conferences
Analysts Are Bullish on These Healthcare Stocks: ScPharmaceuticals (SCPH), Sarepta Therapeutics (SRPT)
ScPharmaceuticals' Earnings Call Highlights Growth and Challenges
A Quick Look at Today's Ratings for ScPharmaceuticals(SCPH.US), With a Forecast Between $11 to $25
Analyst Expectations For ScPharmaceuticals's Future
Maxim Group Maintains Buy on ScPharmaceuticals, Lowers Price Target to $12